<DOC>
	<DOCNO>NCT01081483</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability , pharmacokinetics blind , single ascend oral dos ABT 072 non-fasting condition healthy adult Japanese male subject .</brief_summary>
	<brief_title>A Study Single Doses ABT-072 Japanese Healthy Male Adults</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Overall healthy adult Japanese male Use medication ( prescription overthecounter ) , vitamin , herbal supplement within 2week period prior first dose study drug administration within 10 halflives respective medication , whichever longer . Positive test result hepatitis A virus immunoglobulin M ( HAVIgM ) , hepatitis B surface antigen ( HBsAg ) , hepatitis C virus antibody ( HCV Ab ) , HIV antibody ( HIV Ab ) . Positive screen drug abuse , alcohol , cotinine . Clinically significant cardiovascular , respiratory ( except mild asthma ) , renal , gastrointestinal , hematologic , neurologic , thyroid , uncontrolled medical illness psychiatric disorder . Use tobacco nicotinecontaining product within 6month period precede study drug administration .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Healthy Volunteers</keyword>
	<keyword>HCV Infections</keyword>
</DOC>